Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.

    Prigeon RL, Quddusi S, Paty B, D'Alessio DA.

    Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E701-7. Epub 2003 May 28.PMID: 12773303 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies.

    Braithwaite SS, Barr WG, Rahman A, Quddusi S.

    Postgrad Med. 1998 Nov;104(5):163-6, 171, 175-6.PMID: 9823393 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cushing syndrome due to surreptitious glucocorticoid administration.

    Quddusi S, Browne P, Toivola B, Hirsch IB.

    Arch Intern Med. 1998 Feb 9;158(3):294-6.PMID: 9472211 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...